SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-034357
Filing Date
2019-09-09
Accepted
2019-09-09 16:05:18
Documents
1
Period of Report
2019-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A eypt-8ka_20190909.htm 8-K/A 36682
  Complete submission text file 0001564590-19-034357.txt   37969
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51122 | Film No.: 191083142
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10